Stay updated on First-Line Tarlatamab Combo in ES-SCLC Clinical Trial

Sign up to get notified when there's something new on the First-Line Tarlatamab Combo in ES-SCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the First-Line Tarlatamab Combo in ES-SCLC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The revision label changed from v3.6.4 to v3.6.5, signaling a new version of the page. This represents a backend version update rather than a user-facing content modification.
    Difference
    0.0%
    Check dated 2026-08-10T01:01:05.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.3 to v3.6.4, indicating a new version of the page. This update does not modify the displayed study details or other visible content.
    Difference
    0.0%
    Check dated 2026-07-25T17:00:01.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Revision updated from v3.6.2 to v3.6.3, indicating a minor version update to the page. No substantive study content changes are introduced.
    Difference
    0.0%
    Check dated 2026-07-04T13:38:17.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.2, replacing v3.6.0. This indicates a minor platform update and does not alter study details or participant information.
    Difference
    0.0%
    Check dated 2026-06-27T07:56:57.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    The page adds a recruitment status update indicating no longer looking for participants, clarifying that enrollment is closed. It also adds user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and includes a small formatting adjustment to the Intervention/Treatment header along with a new site revision version (v3.6.0).
    Difference
    0.3%
    Check dated 2026-06-13T01:07:56.000Z thumbnail image
  9. Check
    83 days ago
    Change Detected
    Summary
    Revision updated from v3.5.4 to v3.5.5, indicating a new release of the page template or minor maintenance. This change does not alter study data or user-visible content.
    Difference
    0.0%
    Check dated 2026-06-05T22:11:53.000Z thumbnail image

Stay in the know with updates to First-Line Tarlatamab Combo in ES-SCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the First-Line Tarlatamab Combo in ES-SCLC Clinical Trial page.